Two Regence health plans in Washington have been fined by Insurance Commissioner Mike Kreidler for failing to provide information about the impact of new Hepatitis C drug therapy costs.
When asked for a response, Jared Ishkanian, spokesman for Regence BlueCross BlueShield of Oregon, told The Lund Report that these fines did not involve member care but dealt with data sharing requests from the Insurance Division.
“We are committed to working cooperatively with the OIC to comply with their request for financial information about Hepatitis C therapy costs. We responded to the OIC’s request sincerely, accurately and in good faith with the information we had available at the time. OIC viewed our submission as incomplete, and issued a fine of $10,000 each to Regence and Asuris, which has since been reduced to $5,000 each,” he wrote in an email response.
Diane can be reached at [email protected].